European Journal of Biomedical and Pharmaceutical Sciences

MOLNUPIRAVIR-THE NEXT WONDER DRUG ???

Dr. G. N. Srivastava and Dr. Aparna Suresh*

ABSTRACT

The coronavirus disease 2019 (Covid-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has seen almost 270 million confirmed cases and over 5.2 million reported deaths worldwide.[1] A substantial portion of patients with Covid-19 need hospitalization, predominantly older adults and persons with preexisting conditions (e.g., obesity, diabetes mellitus, and serious cardiac conditions).[2-4] Several vaccines that are highly effective in reducing the incidence of hospitalization and death have been authorized; however, vaccine coverage remains insufficient.[5,6] Antiviral therapies that reduce the risk of Covid-19 progression are needed. Since trials have shown the need for initiation of treatment as soon as possible after the onset of symptoms,[7-9] such therapies would ideally be readily available and easily administered by the patients themselves.[10,11]

Keywords: .